Bonnet, S.; Prévot, G.; Mornet, S.; Jacobin-Valat, M.-J.; Mousli, Y.; Hemadou, A.; Duttine, M.; Trotier, A.; Sanchez, S.; Duonor-Cérutti, M.;
et al. A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis. Int. J. Mol. Sci. 2021, 22, 5188.
https://doi.org/10.3390/ijms22105188
AMA Style
Bonnet S, Prévot G, Mornet S, Jacobin-Valat M-J, Mousli Y, Hemadou A, Duttine M, Trotier A, Sanchez S, Duonor-Cérutti M,
et al. A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis. International Journal of Molecular Sciences. 2021; 22(10):5188.
https://doi.org/10.3390/ijms22105188
Chicago/Turabian Style
Bonnet, Samuel, Geoffrey Prévot, Stéphane Mornet, Marie-Josée Jacobin-Valat, Yannick Mousli, Audrey Hemadou, Mathieu Duttine, Aurélien Trotier, Stéphane Sanchez, Martine Duonor-Cérutti,
and et al. 2021. "A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis" International Journal of Molecular Sciences 22, no. 10: 5188.
https://doi.org/10.3390/ijms22105188
APA Style
Bonnet, S., Prévot, G., Mornet, S., Jacobin-Valat, M.-J., Mousli, Y., Hemadou, A., Duttine, M., Trotier, A., Sanchez, S., Duonor-Cérutti, M., Crauste-Manciet, S., & Clofent-Sanchez, G.
(2021). A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis. International Journal of Molecular Sciences, 22(10), 5188.
https://doi.org/10.3390/ijms22105188